"Abstract
... The US FDA issued an emergency use authorization for the Pfizer-BioNTech COVID-19 mRNA vaccine for the prevention of COVID-19 in individuals ≥ five years. However, concerns were raised after reports of new cases of myocarditis following mRNA COVID-19 vaccines, especially among adolescents and young adults. Most cases developed symptoms after receiving the second dose. Here, we present a case of a previously healthy 34-year-old male who developed sudden and severe chest pain a week after the second dose of the Pfizer-BioNTech COVID-19 mRNA vaccine...
Discussion
The patient presented with new chest pain, shortness of breath, and palpitations along with ST [ECG] abnormalities. The clinical course and investigations of our patient support the diagnosis of a probable case of acute myopericarditis according to the Centers for Disease Control and Prevention (CDC) working case definitions...
© Copyright 2023
Elghazal et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.